GTCs may exert anti-obesity effects through suppression of TNF-α and IL-1β expression, since these inflammatory cytokines are known to upregulate the expression of SREBP-1 and stimulate the maturation of the SREBP-1 protein [71,72,73]. This evidence concerns the gene IL1B and obesity due to melanocortin 4 receptor deficiency.